Drug Type Small molecule drug |
Synonyms Conébilox, HCTZ/nebivolol, Hydrochlorothiazide/nebivolol hydrochloride + [12] |
Mechanism NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors), β1-adrenergic receptor antagonists(Beta-1 adrenergic receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date BE (11 Oct 2012), |
Regulation- |
Molecular FormulaC7H8ClN3O4S2 |
InChIKeyJZUFKLXOESDKRF-UHFFFAOYSA-N |
CAS Registry58-93-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | BE | 11 Oct 2012 |